Exploring the history of generic medicines ‘Generic: the unbranding of modern medicine’ by Jeremy A Greene.…
Breastfeeding mothers may lose out if recent domperidone warnings are heededThe benefits of using domperidone to increase milk supply in breastfeeding mothers outweigh its risks, argues a researcher at the University of Adelaide, South Australia.…
Selective COX-2 inhibitors linked to worse outcomes after ischaemic stroke New research suggests that selective cyclooxygenase-2 inhibitors herald worse outcomes following ischaemic stroke.…
NHS expenditure on prescribed medicines up by 7.6%, with 15.1% increase in hospital sector The cost of medicines prescribed by hospitals in England increased by 15.1% to £5.8bn in 2013–2014 compared with the previous year.…
Heart disease increases cardiac risks of androgen-deprivation therapy Androgen deprivation therapy increases cardiac mortality for men with heart failure or a prior myocardial infarction, research shows.…
Forces driving the evolution of biologics into biosimilars and biobetters As demand for biologics increases, manufacturers are devising strategies to maximise their returns on investment and benefit patients.…
Major bleeding risk higher for dabigatran than for warfarin, study suggests Research suggests that dabigatran is associated with a higher risk of bleeding compared with warfarin in a US population sample.…
Fatal case of progressive multifocal leukoencephalopathy linked to TecfideraA fatal case of progressive multifocal leukoencephalopathy has been reported for the first time in a patient receiving dimethyl fumarate (Tecfidera).…
Breakthrough in targeting KRAS gene mutation implicated in many cancers Researchers have identified an agent that interferes with the cell signalling protein KRAS and which produces a dose-dependent reduction in tumour growth in a mouse model.…
UK bill aims to allow off-patent drugs to be licensed for new purposes A bill going through Parliament wants the National Institute for Health and Care Excellence (NICE) to appraise off-patent drugs to allow them to be used for new indications.…
